Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism "SPACE"


Phase 4 Results N/A

Summary of Purpose

This is a randomized, double blind, placebo-controlled, parallel, multicenter research in order to evaluate the effect of Shuxuetong injection in prevention of symptomatic or asymptomatic new cerebral infarction within 10 days. Subgroup study:Evaluate the role of advanced diagnostic technique in identifying potential causes of Embolic Stroke of Undetermined Source (ESUS).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 November 2017.

12 May 2017 9 Mar 2017 1 Dec 2018 1 Dec 2018 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available